339 related articles for article (PubMed ID: 1337142)
21. Reconstitution of the protein kinase A response of the rat prolactin promoter: differential effects of distinct Pit-1 isoforms and functional interaction with Oct-1.
Diamond SE; Chiono M; Gutierrez-Hartmann A
Mol Endocrinol; 1999 Feb; 13(2):228-38. PubMed ID: 9973253
[TBL] [Abstract][Full Text] [Related]
22. Regulation of the 5'-flanking region of the mouse androgen receptor gene by cAMP and androgen.
Lindzey J; Grossmann M; Kumar MV; Tindall DJ
Mol Endocrinol; 1993 Dec; 7(12):1530-40. PubMed ID: 7511785
[TBL] [Abstract][Full Text] [Related]
23. Regulation of the alpha inhibin gene by cyclic adenosine 3',5'-monophosphate after transfection into rat granulosa cells.
Pei L; Dodson R; Schoderbek WE; Maurer RA; Mayo KE
Mol Endocrinol; 1991 Apr; 5(4):521-34. PubMed ID: 1717833
[TBL] [Abstract][Full Text] [Related]
24. Peptidergic activation of transcription and secretion in chromaffin cells. Cis and trans signaling determinants of pituitary adenylyl cyclase-activating polypeptide (PACAP).
Taupenot L; Mahata SK; Wu H; O'Connor DT
J Clin Invest; 1998 Feb; 101(4):863-76. PubMed ID: 9466982
[TBL] [Abstract][Full Text] [Related]
25. The ras and protein kinase A pathways are mutually antagonistic in regulating rat prolactin promoter activity.
Conrad KE; Gutierrez-Hartmann A
Oncogene; 1992 Jul; 7(7):1279-86. PubMed ID: 1620544
[TBL] [Abstract][Full Text] [Related]
26. CART gene promoter transcription is regulated by a cyclic adenosine monophosphate response element.
Barrett P; Davidson J; Morgan P
Obes Res; 2002 Dec; 10(12):1291-8. PubMed ID: 12490674
[TBL] [Abstract][Full Text] [Related]
27. Transcriptional effects in GH3 cells of Gs alpha mutants associated with human pituitary tumors: stimulation of adenosine 3',5'-monophosphate response element-binding protein-mediated transcription and of prolactin and growth hormone promoter activity via protein kinase A.
Gaiddon C; Mercken L; Bancroft C; Loeffler JP
Endocrinology; 1995 Oct; 136(10):4331-8. PubMed ID: 7664652
[TBL] [Abstract][Full Text] [Related]
28. Dopamine D4 receptor-mediated inhibition of cyclic adenosine 3',5'-monophosphate production does not affect prolactin regulation.
Sanyal S; Van Tol HH
Endocrinology; 1997 May; 138(5):1871-8. PubMed ID: 9112381
[TBL] [Abstract][Full Text] [Related]
29. Role of the cyclic adenosine 3',5'-monophosphate response element in efficient expression of the rat thyrotropin receptor promoter.
Ikuyama S; Shimura H; Hoeffler JP; Kohn LD
Mol Endocrinol; 1992 Oct; 6(10):1701-15. PubMed ID: 1333054
[TBL] [Abstract][Full Text] [Related]
30. Identification of a gonadotropin-releasing hormone-responsive region in the glycoprotein hormone alpha-subunit promoter.
Kay TW; Jameson JL
Mol Endocrinol; 1992 Nov; 6(11):1767-73. PubMed ID: 1282668
[TBL] [Abstract][Full Text] [Related]
31. Selective transcription and DNase I protection of the rat prolactin gene by GH3 pituitary cell-free extracts.
Gutierrez-Hartmann A; Siddiqui S; Loukin S
Proc Natl Acad Sci U S A; 1987 Aug; 84(15):5211-5. PubMed ID: 3474648
[TBL] [Abstract][Full Text] [Related]
32. Identification of positive and negative placenta-specific basal elements and a cyclic adenosine 3',5'-monophosphate response element in the human gene for P450scc.
Moore CC; Hum DW; Miller WL
Mol Endocrinol; 1992 Dec; 6(12):2045-58. PubMed ID: 1337141
[TBL] [Abstract][Full Text] [Related]
33. Transcriptional activation of phosphodiesterase 7B1 by dopamine D1 receptor stimulation through the cyclic AMP/cyclic AMP-dependent protein kinase/cyclic AMP-response element binding protein pathway in primary striatal neurons.
Sasaki T; Kotera J; Omori K
J Neurochem; 2004 Apr; 89(2):474-83. PubMed ID: 15056290
[TBL] [Abstract][Full Text] [Related]
34. Involvement of a cAMP-responsive DNA element in mediating TRH responsiveness of the human thyrotropin alpha-subunit gene.
Kim DS; Ahn SK; Yoon JH; Hong SH; Kim KE; Maurer RA; Park SD
Mol Endocrinol; 1994 Apr; 8(4):528-36. PubMed ID: 7519724
[TBL] [Abstract][Full Text] [Related]
35. Growth factor-induced transcription via the serum response element is inhibited by cyclic adenosine 3',5'-monophosphate in MCF-7 breast cancer cells.
Lowe WL; Fu R; Banko M
Endocrinology; 1997 Jun; 138(6):2219-26. PubMed ID: 9165004
[TBL] [Abstract][Full Text] [Related]
36. Clustered point mutation analysis of the rat prolactin promoter.
Iverson RA; Day KH; d'Emden M; Day RN; Maurer RA
Mol Endocrinol; 1990 Oct; 4(10):1564-71. PubMed ID: 2178221
[TBL] [Abstract][Full Text] [Related]
37. Pit-1 binding sites mediate transcriptional responses to cyclic adenosine 3',5'-monophosphate through a mechanism that does not require inducible phosphorylation of Pit-1.
Okimura Y; Howard PW; Maurer RA
Mol Endocrinol; 1994 Nov; 8(11):1559-65. PubMed ID: 7877624
[TBL] [Abstract][Full Text] [Related]
38. Basal transcriptional activity and cyclic adenosine 3',5'-monophosphate responsiveness of the human cytochrome P450scc promoter transfected into MA-10 Leydig cells.
Hum DW; Staels B; Black SM; Miller WL
Endocrinology; 1993 Feb; 132(2):546-52. PubMed ID: 7678794
[TBL] [Abstract][Full Text] [Related]
39. Cyclic AMP stimulates MEG3 gene expression in cells through a cAMP-response element (CRE) in the MEG3 proximal promoter region.
Zhao J; Zhang X; Zhou Y; Ansell PJ; Klibanski A
Int J Biochem Cell Biol; 2006; 38(10):1808-20. PubMed ID: 16793321
[TBL] [Abstract][Full Text] [Related]
40. In cardiac myocytes, cAMP elevation triggers the down-regulation of transcripts and promoter activity for cyclic AMP phosphodiesterase-4A10 (PDE4A10).
McCahill A; Campbell L; McSorley T; Sood A; Lynch MJ; Li X; Yan C; Baillie GS; Houslay MD
Cell Signal; 2008 Nov; 20(11):2071-83. PubMed ID: 18721873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
